Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)
China
· Delayed Price · Currency is CNY 129.49
+11.77 (10.00%)
Apr 28, 2026, 3:04 PM CST
SHE:002821 Revenue
In the year 2025, Asymchem Laboratories (Tianjin) had annual revenue of 6.67B CNY with 14.91% growth. Asymchem Laboratories (Tianjin) had revenue of 2.04B in the quarter ending December 31, 2025, with 22.59% growth.
Revenue
6.67B
Revenue Growth
+14.91%
P/S Ratio
6.59
Revenue / Employee
652.80K
Employees
10,617
Market Cap
45.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.67B | 865.52M | 14.91% |
| Dec 31, 2024 | 5.80B | -2.02B | -25.82% |
| Dec 31, 2023 | 7.83B | -2.40B | -23.51% |
| Dec 31, 2022 | 10.23B | 5.60B | 120.85% |
| Dec 31, 2021 | 4.63B | 1.50B | 47.67% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sunshine Guojian Pharmaceutical (Shanghai) | 4.32B |
| Beijing Wantai Biological Pharmacy Enterprise | 1.94B |
| Shanghai Allist Pharmaceuticals | 5.67B |
| Pharmaron Beijing | 14.10B |
| Shanghai RAAS Blood Products | 7.35B |
| Hebei Changshan Biochemical Pharmaceutical | 928.01M |
| Chongqing Zhifei Biological Products | 8.75B |
| Haisco Pharmaceutical Group | 5.06B |